0001140361-14-017665.txt : 20140428 0001140361-14-017665.hdr.sgml : 20140428 20140428135658 ACCESSION NUMBER: 0001140361-14-017665 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20140428 DATE AS OF CHANGE: 20140428 EFFECTIVENESS DATE: 20140428 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AntriaBio, Inc. CENTRAL INDEX KEY: 0001509261 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 273440894 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-215538 FILM NUMBER: 14788768 BUSINESS ADDRESS: STREET 1: 890 SANTA CRUZ AVENUE CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 650-847-1919 MAIL ADDRESS: STREET 1: 890 SANTA CRUZ AVENUE CITY: MENLO PARK STATE: CA ZIP: 94025 FORMER COMPANY: FORMER CONFORMED NAME: FITS MY STYLE INC DATE OF NAME CHANGE: 20110104 D/A 1 primary_doc.xml X0707 D/A LIVE 0001509261 AntriaBio, Inc. 890 SANTA CRUZ AVENUE MENLO PARK CA CALIFORNIA 94025 650-241-9330 DELAWARE FITS MY STYLE INC. Fits My Style, Inc. FITS MY STYLE INC Corporation true 2010 Nevan Elam 890 Santa Cruz Avenue Menlo Park CA CALIFORNIA 94025 Executive Officer Director Hoyoung Huh 890 Santa Cruz Avenue Menlo Park CA CALIFORNIA 94025 Director Steve R. Howe 999 18th Street, Suite 3000 Denver CO COLORADO 80202 Director Sankaram Mantripragada 890 Santa Cruz Avenue Menlo Park CA CALIFORNIA 94025 Executive Officer Biotechnology Decline to Disclose 06b true 0001140361-14-016656 2014-03-31 false true true true true Unit = 1 common share and 1 common share purchase warrant. false 0 Paulson Investment Company, Inc. 5670 None None 1331 N.W. Lovejoy, Suite 720 Portland OR OREGON 97209 AZ ARIZONA CA CALIFORNIA CO COLORADO CT CONNECTICUT FL FLORIDA GA GEORGIA IL ILLINOIS MA MASSACHUSETTS MD MARYLAND MI MICHIGAN MN MINNESOTA NJ NEW JERSEY NV NEVADA NY NEW YORK OH OHIO OR OREGON PA PENNSYLVANIA TX TEXAS WA WASHINGTON WI WISCONSIN false 26250000 8931433 17318567 Aggregate offering includes amount that may be received by Issuer upon exercise of warrants. Each warrant may be exercised for 1 common share at a price of $0.39 for a period of 36 months from date of issuance. false 113 1298856 true 0 0 false AntriaBio, Inc. /s/ Nevan Elam Nevan Elam Chief Executive Officer 2014-04-28